![Terig Hughes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terig Hughes
Directeur Financier/CFO chez VOLITIONRX LIMITED
Fortune : 199 998 $ au 30/06/2024
Postes actifs de Terig Hughes
Sociétés | Poste | Début | Fin |
---|---|---|---|
VOLITIONRX LIMITED | Directeur Financier/CFO | 01/02/2021 | - |
Treasurer | 01/02/2021 | - | |
Singapore Volition Pte Ltd.
![]() Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Directeur/Membre du Conseil | 01/09/2021 | - |
Volition Global Services SRL | Directeur/Membre du Conseil | 02/09/2021 | - |
Volition America, Inc.
![]() Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Directeur Financier/CFO | 01/12/2022 | - |
Treasurer | 01/12/2022 | - | |
Volition Veterinary Diagnostics Development LLC | Directeur Financier/CFO | 17/03/2023 | - |
Treasurer | 17/03/2023 | - |
Historique de carrière de Terig Hughes
Anciens postes connus de Terig Hughes
Sociétés | Poste | Début | Fin |
---|---|---|---|
AUM Biosciences Pte Ltd.
![]() AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi. | Directeur Financier/CFO | 01/01/2018 | 01/01/2020 |
RELX Group Plc
![]() RELX Group Plc Packaged SoftwareTechnology Services RELX Group Plc engages in the provision of information and analytics for professional and business customers. It operates in four major segments such as scientific, technical and medical, risk and business analytics, legal and exhibitions. The company was founded on September 11, 1992 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2014 | 01/01/2017 |
Elsevier, Inc.
![]() Elsevier, Inc. Publishing: Books/MagazinesConsumer Services Elsevier, Inc. publishes journals, online materials, and books. It offers Scopus, ScienceDirect, Mendeley, Evolve, Knovel, Reaxys and ClinicalKey. The company is headquartered in Newton, MA. | Corporate Officer/Principal | 01/01/2003 | 01/01/2006 |
Formation de Terig Hughes
De Montfort University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Royaume-Uni | 3 |
Singapour | 3 |
Opérationnelle
Director of Finance/CFO | 4 |
Treasurer | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Consumer Services | 3 |
Health Services | 3 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
VOLITIONRX LIMITED | Health Technology |
Entreprise privées | 7 |
---|---|
Elsevier, Inc.
![]() Elsevier, Inc. Publishing: Books/MagazinesConsumer Services Elsevier, Inc. publishes journals, online materials, and books. It offers Scopus, ScienceDirect, Mendeley, Evolve, Knovel, Reaxys and ClinicalKey. The company is headquartered in Newton, MA. | Consumer Services |
RELX Group Plc
![]() RELX Group Plc Packaged SoftwareTechnology Services RELX Group Plc engages in the provision of information and analytics for professional and business customers. It operates in four major segments such as scientific, technical and medical, risk and business analytics, legal and exhibitions. The company was founded on September 11, 1992 and is headquartered in London, the United Kingdom. | Technology Services |
Singapore Volition Pte Ltd.
![]() Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Health Services |
Volition America, Inc.
![]() Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Health Services |
AUM Biosciences Pte Ltd.
![]() AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi. | Commercial Services |
Volition Veterinary Diagnostics Development LLC | |
Volition Global Services SRL |
- Bourse
- Insiders
- Terig Hughes
- Expérience